NIH #5P50CA210964-07
Biospecimens Core
- Amount
- $286K
- Period
- 2018-09-10 → 2029-08-31
- PIs
- 1
- Est. capacity / PI
- ~1 students
Awarded at MAYO CLINIC ROCHESTER
Liver Disease Diagnosis and Treatment · Epidemiology
18 total · 2 active
NIH #5P50CA210964-07
Awarded at MAYO CLINIC ROCHESTER
NIH #2P50CA210964-06A1
Awarded at MAYO CLINIC ROCHESTER
NIH #5P50CA210964-05
Awarded at MAYO CLINIC ROCHESTER
Student capacity is a rough estimate from remaining award size, split equally among PIs. Actual funding decisions vary.
Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.
2026-06-17
2026-06-17
2026-06-17
1568 PSMA Expression in Pediatric Liver Tumors
Laboratory Investigation · 2026-03-01
Human Pathology · 2025-10-23 · 6 citations
The Oncologist · 2025-09-18 · 3 citations
1183: TP53 MUTATION IS A KEY PROGNOSTIC FACTOR IN HUMAN HEPATOCELLULAR CARCINOMA
Gastroenterology · 2025-05-01
Erratum for: Autoimmune Disorders of the Liver and Biliary Tract
Radiographics · 2025-04-01
Autoimmune Disorders of the Liver and Biliary Tract
Radiographics · 2025-03-20
1425 Hepatic Amyloidosis is an Underrecognized Cause of Cholestatic Clinical Presentation
Laboratory Investigation · 2025-03-01
Laboratory Investigation · 2025-03-01
Nature Communications · 2024-12-30 · 12 citations
Liver International · 2024-12-12 · 12 citations
Frontiers in Nuclear Medicine · 2024-11-27 · 6 citations
Cancer Research · 2024-09-05
The Journal of Pathology Clinical Research · 2024-09-01 · 3 citations
2024-08-15
2024-08-15
2024-08-15
2024-08-15